VALENCIA, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (RCEL) (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound ...
VALENCIA, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced ...
Please provide your email address to receive an email when new articles are posted on . Regenity will cover manufacturing and Avita will lead marketing and distribution. The product generates a dermal ...
A recent study reveals a promising solution to India's oral cancer crisis, using Acellular Dermal Matrix (ADM) for simpler, faster recovery post-surgery.
The US Food and Drug Administration has approved the Integra Dermal Regeneration Template (Integra LifeSciences) for the additional indication of the treatment of nonhealing diabetic foot ulcers. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results